Sabine Steffens

Preventive Cardiology

Helmholtz Zentrum München

About

Sabine Steffens works in Preventive Cardiology affiliated with Helmholtz Zentrum München.

Sabine Steffens is a W2 Professor of Clinical Pathobiochemistry at the Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, and an Associated Group Leader in Cardiovascular Disease Comorbidities at the Institute for Diabetes and Cancer, Helmholtz Munich. Her research investigates the role of endogenous lipid signaling pathways in inflammatory processes underlying atherosclerosis and adverse cardiac remodeling. She previously served as a postdoc and junior group leader at the Medical Faculty of Geneva from 2003 to 2013.

Research focus

Atherosclerosis PathogenesisEndocannabinoid System in Cardiovascular InflammationNeutrophil-Mediated Cardiac RepairCircadian Rhythms in Immune ResponsesLipid Signaling in Metabolic Diseases

Impact

171 pubs · 11,470 cites · h-index 60

Training

Habilitation
Medical Faculty of Geneva
2012
PhD
Heinrich-Heine-University Düsseldorf
2001
Diploma in Biology
Justus-Liebig-University Giessen
1998

Affiliations

Work Experience

Associated Group Leader, Cardiovascular Disease Comorbidities

Institute for Diabetes and Cancer, Helmholtz Munich · 2024 - Present

W2 Professor of Clinical Pathobiochemistry

Institute for Cardiovascular Prevention, LMU Munich · 2013 - Present

Postdoc and Junior Group Leader

Medical Faculty of Geneva · 2003 - 2013

DFG Postdoc Fellow

Children's Hospital of Philadelphia · 2012 - 2012

Publications